1-(beta-D-Ribofuranosyl)pyrrole-2-carbaldehyde → 4-Propynyl-1-(beta-D-ribofuranosyl)pyrrole-2-carbaldehyde
Reaktionsgleichung
[C@@H:1]1([N:10]2[CH:14]=[CH:13][CH:12]=[C:11]2[CH:15]=[O:16])[O:7][C@H:6]([CH2:8][OH:9])[C@@H:4]([OH:5])[C@H:2]1[OH:3].[C:17]([C:20]1C=C(C=O)NC=1)#[C:18]C>>[C:18]([C:13]1[CH:12]=[C:11]([CH:15]=[O:16])[N:10]([C@@H:1]2[O:7][C@H:6]([CH2:8][OH:9])[C@@H:4]([OH:5])[C@H:2]2[OH:3])[CH:14]=1)#[C:17][CH3:20]Komponenten
3
Versuchsvorschrift
4-Propynyl-1-(β-D-ribofuranosyl)pyrrole-2-carbaldehyde (Compound 18) was synthesized in the same manner as used for Compound 17, starting with 4-propynyl-2-pyrrolecarbaldehyde (Compound 16) (Non-patent Document 40) (266 mg, 2.0 mmol). After purification by RP-HPLC, Compound 18 was obtained (39 mg, 7%, 2 steps).
Aufarbeitung
- custom4-Propynyl-1-(β-D-ribofuranosyl)pyrrole-2-carbaldehyde (Compound 18) was synthesized in the same manner
- customAfter purification by RP-HPLC
Quellen und Nachweise
- ORD-Eintrag
- ord-95b5060e29264edd80ee125312182c2c
- Quelldatensatz
- uspto-grants-2011_10
- Patentnummer
- US08030478B2
Notizen zur Reaktion
Wird geladen…